About Sagent Pharma
Sagent Pharma is a Healthcare company based in Schaumburg (United States) founded in 2006, and was acquired by Nichi-Iko Pharmaceutical in July 2016. Injectable generic pharmaceuticals are supplied across multiple therapeutic categories. Sagent Pharma has raised $153 million across 5 funding rounds from investors including MidCap Financial, Zhejiang Hisun Pharmaceuticals and Nichi-Iko Pharmaceutical. Sagent Pharma has completed 1 acquisition, including Omega Laboratory. Its website sagentpharma.com draws about 16 thousand monthly visits. Sagent Pharma offers products and services including Injectable Pharmaceuticals and PreventIV Measures Packaging. Its focus areas include Traditional Pharmaceuticals, Generics and Injectables. Its legal entity in India is Sagent Pharma Services (India) Private Limited (U62099TS2023FTC175890).
Company details
Sagent Pharma was founded in 2006 and is headquartered in Schaumburg, United States, within the pharmaceuticals sector. Injectable generic drugs are manufactured and distributed in formats such as vials, syringes, and premix bags. Products cover various therapeutic areas, with smart labeling implemented to minimize medication errors. Assistance is provided to healthcare providers and patients through dedicated support services.
- Headquarters Schaumburg, United States
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website sagentpharma.com
- Social LinkedIn
- Acquired by Nichi-Iko Pharmaceutical (Jul 2016)
- Legal Name Sagent Pharma Services (India) Private Limited
- Date of Incorporation 09 Aug, 2023
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue$318.3 M (USD)10as on Dec 31, 2015
- Net Profit-$21.88 M (USD)-159as on Dec 31, 2015
- EBITDA-$44.52 M (USD)-334as on Dec 31, 2015
- Total Equity Funding$153M (USD)
in 5 rounds
- Latest Funding Round$40M (USD), Series B
Apr 2010
- InvestorsMidCap Financial
& 3 more
- Investments & Acquisitions
- Acquired byNichi-Iko Pharmaceutical
(Jul 2016)
Associated legal entities of Sagent Pharma
Sagent Pharma operates through Sagent Pharma Services (India) Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sagent Pharma Services (India) Private Limited CIN U62099TS2023FTC175890 | Active | 09 Aug 2023 | Hyderabad, Telangana | 10 | 4 | View details |
Products & Services of Sagent Pharma
Sagent Pharma offers a comprehensive portfolio of products and services, including Injectable Pharmaceuticals and PreventIV Measures Packaging.
Injectable drugs are supplied in various therapeutic categories and packaging configurations to meet healthcare needs.
Packaging and labeling services are offered to minimize medication errors in clinical environments.
Funding Insights of Sagent Pharma
Sagent Pharma has successfully raised a total of $153M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $40 million completed in April 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $153M
- Total Rounds 5
- Last Round Series B — $40M
- First Round $53M
(Sep 2007)
- Investors Count 3
All 5 funding rounds of Sagent Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2010 | $40M | Series B | – | Zhejiang Hisun Pharmaceuticals | – |
| Jun 2009 | $15M | Debt – Venture | – | – | |
| May 2009 | $30M | Series A | – | – | |
| Sep 2008 | $30M | Series A | – | – | |
| Sep 2007 | $53M | Series A | – | – |
4 investors in total: 4 institutional.
Investors in Sagent Pharma
Sagent Pharma has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include MidCap Financial, Zhejiang Hisun Pharmaceuticals and Nichi-Iko Pharmaceutical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private debt funds are managed across multiple sectors. | 2008 | midcapfinancial.com | Bethesda, United States | |
Venture capital and private equity firm | vivocapital.com | Palo Alto, United States | ||
Pharmaceutical APIs, formulations, and animal health products are manufactured. | 1956 | hisunpharm.com | Taizhou, China | |
Generic and biosimilar pharmaceuticals are developed, manufactured, and distributed. | 1965 | nichiiko.co.jp | Toyama, Japan |
Investor details for Sagent Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Sagent Pharma Services (India) Private Limited (Sagent Pharma)
Sagent Pharma Services (India) Private Limited is the primary company behind Sagent Pharma. The board of Sagent Pharma Services (India) Private Limited currently have 4 directors; the longest-serving is Jeffrey William Greve, appointed in 2023.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jeffrey William Greve DIN 10273523 | Non- Individual Subscriber | 09 Aug 2023 | 3 yrs 2 mo | Sagent Pharma Services (India) Private Limited |
| Venkata Sashikanth Pochimcharla DIN 10273524 | Director | 09 Aug 2023 | 3 yrs 2 mo | Sagent Pharma Services (India) Private Limited |
| Viswanath Venkata Subrahmanya Anjaneya Chibrolu DIN 01556254 | Director | 09 Aug 2023 | 3 yrs 2 mo | Sagent Pharma Services (India) Private Limited |
| Prakash Vithal Baliga DIN 10850033 | Additional Director | 26 Nov 2024 | 1 yr 11 mo | Sagent Pharma Services (India) Private Limited |
People of Sagent Pharma
40 people are tracked at Sagent Pharma (7 in leadership, 33 in team).
| Name | Role | Group |
|---|---|---|
Iwona Caldwell, CPA | Director Of Accounting | Leadership |
Peter Kaemmerer | CEO | Leadership |
Richard Peterman | Sr. Director, Pricing, Contracting, and Business Analytics | Leadership |
Eric Schier | Director Regional Sales | Leadership |
Kara Hoehn, SHRM-CP | Human Resources Director | Leadership |
Bob Szurgot | VP Specialty Pharmaceuticals | Leadership |
Tim Emling | Director Regional Sales | Leadership |
Mark Michalik | Analyst | Team |
Penny Perez | Urology Business Manager | Team |
Chad Fox | National Account Manager - Distribution | Team |
Brennan Bolt | General Counsel & Corporate Secretary | Team |
Don Bullock | EVP, Sales & National Accounts | Team |
Jeff Greve | EVP, Global Finance | Team |
Paul Cody Smith | Senior Financial Analyst | Team |
Sandra Dimopoulos | Information Technology Business Analyst | Team |
Jojhar Bagri | Manager, Commercial Business Analysis | Team |
Nicole A Agnello | Manager, It- Quality And Regulatory Systems | Team |
Stephanie Everest Batey | Regional Business Manager | Team |
Benny Tart | Regional Business Manager | Team |
Jason Kupisch | Inside Sales Specialist | Team |
20 more people are available in the full profile.
Complete people profiles for Sagent Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sagent Pharma
Sagent Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Omega Laboratory.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Specialized sterile products are manufactured for hospitals and providers. | omegalaboratory.com | Montreal, Canada | 1958 | Oct 2014 | $85.3M |
Complete acquisition details for Sagent Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Sagent Pharma
6 dated milestones of Sagent Pharma across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Sagent Pharma is founded.
- Funding First funding round of $53.0M.
- Funding Latest funding round, Series B, of $40.0M.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Omega Laboratory.
- Exit Acquired by Nichi-Iko Pharmaceutical.
Web traffic of Sagent Pharma
The website of Sagent Pharma (sagentpharma.com) receives about 16.1K visits a month and ranks #1,111,836 among all websites worldwide, #1,377 in Biotechnology and Pharmaceuticals.
- Monthly visits16.1K
▲ 15.8% vs previous month
- Unique visitors4.5K
per month
- Global rank#1,111,836
among all websites
- Category rank#1,377
Health · Biotechnology and Pharmaceuticals
- Bounce rate22%
- Pages per visit8.1
- Average visit3 min 08 sec
- DevicesDesktop 47% · Mobile 53%
Websites whose visitors overlap most with Sagent Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| akorn.com | 100% | #11,843,991 | View details | ||
| rigel.com | 78% | 9.2K | #2,021,438 | View details | |
west-ward.com | west-ward.com | 75% | – | ||
| progenics.com | 73% | View details | |||
| ironwoodpharma.com | 73% | 20.5K | #2,523,580 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 18 similar websites and full traffic analytics for Sagent Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 18 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Sagent Pharma (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sagent Pharma
Sagent Pharma was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Sagent Pharma is headquartered in Schaumburg, United States. It is registered at Schaumburg, Illinois, United States.
Sagent Pharma is a funded company, having raised a total of $153M across 5 funding rounds to date. The company's 1st funding round was a Series A of $53M, raised on Sep 2007.
Annual revenue of Sagent Pharma is $318.3M as on Dec 31, 2015.
Sagent Pharma was founded in 2006 and is headquartered in Schaumburg, United States, within the pharmaceuticals sector. Injectable generic drugs are manufactured and distributed in formats such as vials, syringes, and premix bags. Products cover various therapeutic areas, with smart labeling implemented to minimize medication errors. Assistance is provided to healthcare providers and patients through dedicated support services.
Sagent Pharma offers Injectable Pharmaceuticals and PreventIV Measures Packaging.
Sagent Pharma has made 1 acquisition, including Omega Laboratory.
Sagent Pharma has 4 investors. Key investors include MidCap Financial, Zhejiang Hisun Pharmaceuticals, Nichi-Iko Pharmaceutical, and Vivo Capital.
Sagent Pharma operates through Sagent Pharma Services (India) Private Limited.
Yes. Sagent Pharma was acquired by Nichi-Iko Pharmaceutical in July 2016.
The legal entities of Sagent Pharma currently have 4 directors, including Jeffrey William Greve, Venkata Sashikanth Pochimcharla, Viswanath Venkata Subrahmanya Anjaneya Chibrolu and others.